La maladie de Parkinson en France (serveur d'exploration)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Eléments de l'association

Suisse244
F. Durif61
Suisse Sauf F. Durif" 241
F. Durif Sauf Suisse" 58
Suisse Et F. Durif 3
Suisse Ou F. Durif 302
Corpus9014
\n\n\n\n \n

List of bibliographic references

Number of relevant bibliographic references: 3.
Ident.Authors (with country if any)Title
002105 N. Kickler [France, Suisse] ; E. Lacombe [France] ; C. Chassain [France] ; F. Durif [France] ; A. Krainik [France] ; R. Farion [France] ; P. Provent [France] ; C. Segebarth [France] ; C. Rémy [France] ; M. Savasta [France]Assessment of metabolic changes in the striatum of a rat model of parkinsonism: an in vivo 1H MRS study
003260 G. Fenelon [France] ; S. Gimenez-Roldan [Espagne] ; J. L. Montastruc [France] ; F. Bermejo [Espagne] ; F. Durif [France] ; I. Bourdeix [France] ; J.-J. Pere [Espagne] ; L. Galiano [Suisse] ; J. SchadrackEfficacy and tolerability of entacapone in patients with Parkinson's disease treated with levodopa plus a dopamine agonist and experiencing wearing-off motor fluctuations. A randomized, double-blind, multicentre study
003833 F. Durif [France] ; I. Devaux [France] ; J.-J. Pere [France] ; J.-C. Delumeau [Suisse] ; I. Bourdeix [France]Efficacy and tolerability of entacapone as adjunctive therapy to levodopa in patients with Parkinson's Disease and end-of-dose deterioration in daily medical practice : An open, multicenter study

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024